Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bromhexine and hydroxychloroquine for hospitalized adults with COVID-19
IRCT20200818048444N4Phase 3Completed
- Sponsor
- Tabriz University of Medical Sciences
- Start
- Nov 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised trial of bromhexine and hydroxychloroquine in coronavirus disease 2019 (COVID-19) (4 arms), sponsored by Tabriz University of Medical Sciences. Primary endpoints: Intensive care transfer, Intubation and 2 more. Started Nov 2021; status: completed.
02
Drugs
bromhexinehydroxychloroquine
03
Conditions
coronavirus disease 2019 (COVID-19)
Beyond the preview
Go deeper on IRCT20200818048444N4.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20200818048444N4.